Super-TDU (1-31) (TFA)
PRODUCTS SPECIFICATIONS
DESCRIPTION
Overview
| MDL | - |
|---|---|
| Molecular Weight | 3355.50 |
| Molecular Formula | C141H218N40O48.C2HF3O2 |
| SMILES | - |
1 Publications Citing Use of MCE
Summary
In Vitro
Super-TDU (1-31) TFA (50 nM; 24-72 hours) can largely compromise the increased cell viability induced by ACTN1 in Huh-7 or LM3 cells proliferation [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [2]
| Cell Line: | Liver cancer cell lines of human, including Huh-7, LM3 cells |
| Concentration: | 50 nM |
| Incubation Time: | 24, 48 and 72 h |
| Result: | Could largely compromise the increased cell viability induced by ACTN1. |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Sealed storage, away from moisture and light
| Powder | -80°C | 2 years |
|---|---|---|
| -20°C | 1 year |
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvent & Solubility
H 2 O : 50 mg/mL ( 14.90 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 0.2980 mL | 1.4901 mL | 2.9802 mL |
| 5 mM | 0.0596 mL | 0.2980 mL | 0.5960 mL |
| 10 mM | 0.0298 mL | 0.1490 mL | 0.2980 mL |
References
- [1] Jiao S, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014 Feb 10;25(2):166-80.
- [2] Qian Chen, et al. ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2021 Jan 7;40(1):23.